stockrowEli Lilly and Company
LLY Healthcare Drug Manufacturers General
Eli Lilly and Company’s revenue for fiscal 2025 (year ended December 2025) was $65.2 billion, up 44.7% from fiscal 2024.
- Revenue
- +38.6%
- EPS
- +16.3%
- Free cash flow
- +21.8%
- Total debt
- +15.0%
Quarter to September 2026, against a year earlier
Follow LLY
Alert me
Eli Lilly and Company (LLY) Operating margin
Eli Lilly and Company's operating margin over the twelve months to 30 September 2026 was 40.3%, down 0.1 percentage points from fiscal 2025 (40.4%). Over the past ten years it has ranged from 10.0% (fiscal 2017) to 40.4% (fiscal 2025) — the current reading is the highest in ten years. That is above the Drug Manufacturers General industry median of 18.3% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 40.4% | 11.71 |
| FY2024 | 28.6% | 9.72 |
| FY2023 | 18.9% | (6.05) |
| FY2022 | 25.0% | 2.52 |
| FY2021 | 22.5% | (2.24) |
| FY2020 | 24.7% | 2.40 |
| FY2019 | 22.3% | 5.85 |
| FY2018 | 16.4% | 6.41 |
| FY2017 | 10.0% | (5.34) |
| FY2016 | 15.4% | 1.90 |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | 36.5% | (2.56) |
| Jun 2026 | 39.1% | (5.95) |
| Mar 2026 | 45.0% | 3.51 |
| Dec 2025 | 41.5% | (2.40) |
| 43 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| LLY Eli Lilly and Company | 40.3% |
| AMGN Amgen Inc. compare | 32.4% |
| ABBV AbbVie Inc. compare | 32.2% |
| NVS Novartis AG compare | 25.2% |
| AZN AstraZeneca PLC compare | 23.7% |
| PFE Pfizer Inc. compare | 21.4% |
| JNJ Johnson & Johnson compare | 19.7% |
| MRK Merck & Co., Inc. compare | 9.20% |
| GILD Gilead Sciences, Inc. compare | −7.63% |
| Drug Manufacturers General industry median | 18.3% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on LLY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement